Executive Chairman & CEO of Raffles Medical Group Choon Yong Loo Buys More Stock
Raffles Medical Group (SGX:BSL) Could Be A Buy For Its Upcoming Dividend
These 4 Measures Indicate That Raffles Medical Group (SGX:BSL) Is Using Debt Reasonably Well
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Raffles Interior Returns to Profit in 2023 as Revenue Surges
Raffles Interior (HKG:1376) returned to an attributable profit of SG$1.4 million, or SG$0.0014 per share, in 2023 from a loss of SG$1.4 million, or SG$0.0014 per share, in 2022, according to a Tuesday
Raffles Medical Group Announces Board Changes
Raffles Medical Group's (SGX:BSL) Returns Have Hit A Wall
Gim Lian Chung Spends S$638k Buying Raffles Education Shares
Investors who take an interest in Raffles Education Limited (SGX:NR7) should definitely note that insider Gim Lian Chung recently paid S$0.046 per share to buy S$638k worth of the stock. Although t
Raffles Medical Group Full Year 2023 Earnings: EPS Misses Expectations
Raffles Medical Group (SGX:BSL) Will Pay A Smaller Dividend Than Last Year
Raffles Medical Group Ltd (SGX:BSL) Shares Could Be 34% Below Their Intrinsic Value Estimate
CoinRaffle.io Unveils Innovative Platform for Secure and Fair Decentralized Raffles
Willemstad, Curaçao, March 29, 2024 (GLOBE NEWSWIRE) -- The CoinRaffle.io project has proudly launched its utility-focused platform, which relies on decentralized technology. This innovative solution enables projects
Prime Grade Office Rents in Raffles Place, Marina Bay up 0.6% QoQ in Q1
Raffles Medical Chair Continues Purchases; Sam Goi Ups PSC Stake
Institutions were net buyers of Singapore stocks over the five trading sessions through to Mar 21, with S$257 million of net institutional inflow, as 23 primary-listed companies conducted buybacks wit
RAFFLES INTERIOR (01376.HK) annual revenue increased by about 37.1% to approximately SGD 91.2 million
On March 22, GLONGHUI | RAFFLES INTERIOR (01376.HK) announced that the company's overall revenue increased by about SGD 24.7 million, or about 37.1%, from approximately SGD 66.5 million for the year ended December 31, 2022 to approximately SGD 91.2 million for the year ended December 31, 2023. This increase is mainly due to (i) an increase in orders carried over from 2022; and (ii) additional projects acquired in the first half of 2023. Profit attributable to company owners is a loss contract for the year ended 31 December 2022
Loo Continues Raffles Medical Share Spree as Weekly Tally Climbs to 500,000 Units
Raffles Financial Group Secures Asset Transfer
Raffles Medical CEO Loo Acquires 100,000 Shares at $1.03 Each
Raffles Medical Executive Chair Continues Acquisitions, CDL Leads Buyback Consideration
GRAPHIC: HANNAH KWAHInstitutions were net sellers of Singapore stocks over the five trading sessions through to Mar 14, with S$156 million of net institutional outflow, as 24 primary-listed companies
RAFFLES INTERIOR (01376.HK) Earnings: Net profit after tax is expected to turn a loss into a profit of not more than S$1.5 million in 2023
Gelonghui March 15 | RAFFLES INTERIOR (01376.HK) announced that it is expected that the Group will turn loss into profit and record net profit after tax of not more than S$1.5 million for the year ended December 31, 2023 (December 31, 2022: net loss of approximately S$1.363 million). The conversion from loss to profit was mainly driven by revenue and gross profit growth in FY2023, which was due to (i) an increase in the number of orders carried forward from 2022; and (ii) acquisition of additional projects in the first half of 2023.
An Intrinsic Calculation For Raffles Medical Group Ltd (SGX:BSL) Suggests It's 34% Undervalued
Key Insights Raffles Medical Group's estimated fair value is S$1.58 based on 2 Stage Free Cash Flow to Equity Raffles Medical Group is estimated to be 34% undervalued based on current share price of
No Data